secwatch.observer — SEC 8-K summary
======================================

Issuer:     Ginkgo Bioworks Holdings, Inc. (DNA)
CIK:        0001830214
Form:       8-K
Filed at:   2022-11-18T23:59:59+00:00
Accession:  0001193125-22-289107
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Ginkgo Bioworks closes $99.1M bought-deal equity offering of 41.4M shares
-------------------------------------------------------------------------

- Bought deal of 41,383,877 shares at $2.4164/share; net proceeds ~$99.1M after expenses.
- Underwriter granted 30-day option to purchase up to 6,207,581 additional shares at same price.
- Proceeds offset $80M cash used for Bayer CropScience asset acquisition and strengthen balance sheet.
- Offering closed on November 18, 2022; underwriter BTIG, LLC.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1830214/000119312522289107/0001193125-22-289107-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1830214/000119312522289107/d411326d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-289107

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer